Big name investors take sides on Ackman bet on Valeant: filings
May 15, 2015 at 16:45 PM EDT
BOSTON (Reuters) - Wall Street's savviest investors are picking sides on Bill Ackman's new bet on Valeant Pharmaceuticals International Inc , with BlueMountain Capital and T. Rowe Price adding money, while Viking Global Investors and Jana Partners cut stakes.
